Results 211 to 220 of about 82,493 (288)

Vitamin D Level and Antibody Response to the BBIBP-CorV Vaccine in Pregnant Women. [PDF]

J Trop Med
Falahi S, Vahabi M, Sayyadi H, Kenarkoohi A.   +3 more
europepmc   +1 more source

Immune parameters in hospitalized COVID-19 patients during SARS-CoV2 delta and omicron waves. [PDF]

Clinics (Sao Paulo)
Magalhães GS, Gimenes SNC, Távora BCLF, Portes Junior JA, Calabria PAL, Montealegre-Sanchez LI, Vessoni SCS, Massad E, Lamas CA, Muller SS, Tozetto-Mendoza TR, Mendes-Correa MC, Carvalho CRR, Faquim-Mauro EL.   +13 more
europepmc   +1 more source

AI-guided epitope engineering of a SARS-CoV-2 spike antigen for broad sarbecovirus neutralization. [PDF]

Front Immunol
Odainic A, Vardaxis I, Ferraz M, Wiese KE, Cornelissen LAHM, Sharma A, Stratford R, Clancy T, Bendjama K.   +8 more
europepmc   +1 more source

Potent type-specific de novo antibodies complement broadly reactive imprinted antibodies in immune responses to SARS-CoV-2 variants. [PDF]

Nat Immunol
Johnston TS, Li SH, Painter MM, Swaminathan D, Atkinson RK, Dadonaite B, Wang S, Douek NR, Kampman L, Schlesinger R, Kazmierski R, Lin BC, Serebryannyy LA, Du H, Henry AR, Smith SC, Laboune F, Teng IT, Wang L, Doria-Rose NA, Schramm CA, Pierson TC, Zhou T, Bloom JD, Wherry EJ, Hensley SE, Douek DC.   +26 more
europepmc   +1 more source

Allosteric effects of CDR-H3 mutations modulate binding and neutralization of a conserved SARS-CoV-2 RBD-targeting antibody. [PDF]

Microbiol Spectr
Nasir MW, Liang Q, He J, Rashid U, Wu J, Gao Y.   +5 more
europepmc   +1 more source

ACE2-fused nanobody targeting a cryptic RBD epitope broadly neutralizes SARS-like viruses. [PDF]

J Virol
Zeng W, Zhang G, Ma H, Xiong L, Xu M, Wang S, Huang X, Chen S, Chi X, Chiu S, Jin T.   +10 more
europepmc   +1 more source